Jonathan Edwards
Senior Member (Voting Rights)
But many about the same treatment could mean a possibility.
That kept scams like blood-letting and homeopathy going for centuries.
But many about the same treatment could mean a possibility.
There are thousands of compounds out there that hasn't been tried.
It doesn't need to be rare, expensive, risky drugs. Two of my most effective treatments (cumin and iodine) were already in my kitchen. They haven't had the same effects on anyone else, but they were very effective for my ME. I wouldn't be surprised if there are a significant number of people who developed ME but effectively treated or cured it with common foodstuffs or drugs, and never realized that they had ME (just feeling under the weather, maybe a bug). There might be some relatively common foodstuff or herbal remedy that has helped people, but we don't know about it because they didn't know it was valuable information for the ME community.Randomly testing drugs is like playing the lottery to get rich instead of investing over time.
It doesn't need to be rare, expensive, risky drugs. Two of my most effective treatments (cumin and iodine) were already in my kitchen. They haven't had the same effects on anyone else, but they were very effective for my ME. I wouldn't be surprised if there are a significant number of people who developed ME but effectively treated or cured it with common foodstuffs or drugs, and never realized that they had ME (just feeling under the weather, maybe a bug). There might be some relatively common foodstuff or herbal remedy that has helped people, but we don't know about it because they didn't know it was valuable information for the ME community.
I agree that investing in expensive drug testing is a poor choice. Inexpensive testing of common herbs&spices or other such things might be a reasonable investment. A campaign to request PWME to report possible treatments that worked for them wouldn't be expensive, and might turn up something useful. Reports of negative responses, such as "Turmeric made me crash for 6 months." might be helpful too.
This has already been done, it didn’t really show anything you wouldn’t be able to find by spending a bit of time in a Facebook group etc.A campaign to request PWME to report possible treatments that worked for them wouldn't be expensive, and might turn up something useful.
Why dismiss them out of hand? If many people report blood-letting or homeopathy improving their condition, then we should do a trial.That kept scams like blood-letting and homeopathy going for centuries.
Those are possibilities too. We should let a trial, like the one for glucosamine for cartilage, settle the question rather than dismissing them out of hands. As long as they are promising.Or that enough people have tried it in the same time period as a natural positive fluctuation of their illness.
Or that people report that it works because they want it to work.
RECOVER wasted colossal amount of money doing the "basic research". All they did was reinvent the wheel. We might have something useful by now if they spent some on figuring out potentially useful repurposed drugs and trialed promising ones.We barely have enough funds to cover basic research. Some researchers even have to ask for donations or work in their spare time.
Individually, that is true. I'm thinking there could be a systematic way to do this collectively. If AI can speed up the process with pennies, that would be great. Or there might be a statistical Monte Carlo method to do this effectively and sort through thousands to find a needle in haystack.Randomly testing drugs is like playing the lottery to get rich instead of investing over time.
This is something I've been saying for a while: white box is not the only way to figure out things. You can do that to some degree even with black box. The way things going, I don't think any of us will be alive to see the solution if we relied solely on the white box approach.We have no idea about how ME/CFS works, so we don’t have anything to check the drugs against yet. This approach will have to wait until we have more to go on.
https://www.s4me.info/threads/malic-acid-supplement-sumac.42716/page-4#post-594525It doesn't need to be rare, expensive, risky drugs. Two of my most effective treatments (cumin and iodine) were already in my kitchen.
RECOVER wasted colossal amount of money doing the "basic research". All they did was reinvent the wheel. We might have something useful by now if they spent some on figuring out potentially useful repurposed drugs and trialed promising ones.
If something is dismissed by people on the forum it’s most likely because there isn’t enough evidence to warrant a trial.We should let a trial, like the one for glucosamine for cartilage, settle the question rather than dismissing them out of hands. As long as they are promising.
We most likely wouldn’t because we have no idea about what we’re trying to do with the treatments.RECOVER wasted colossal amount of money doing the "basic research". All they did was reinvent the wheel. We might have something useful by now if they spent some on figuring out potentially useful repurposed drugs and trialed promising ones.
Again, we do not know what we are lookikg for. AI isn’t some magic wand you can wave. It has to have something to go on.Individually, that is true. I'm thinking there could be a systematic way to do this collectively. If AI can speed up the process with pennies, that would be great. Or there might be a statistical Monte Carlo method to do this effectively and sort through thousands to find a needle in haystack.
It doesn’t seem like you’re considering how many possibilities the black box contains.This is something I've been saying for a while: white box is not the only way to figure out things. You can do that to some degree even with black box. The way things going, I don't think any of us will be alive to see the solution if we relied solely on the white box approach.
We should let a trial, like the one for glucosamine for cartilage, settle the question rather than dismissing them out of hands.
Have they still not done a GWAS on Long Covid? Will DecodeME be the only GWAS to include PwLC?As far as I can gather RECOVER wasted money on dumb research. 95% of research is dumb so not surprising. If they had set up a GWAS like DecodeME in late 2020 on 100,000 people we would have the answers now for a fraction the cost.
We've discussed this before, how to properly interpret and take advantage of individual PwME trying things that they're taking outside of a clinical trial. I think we concluded that the thing to do was to then proceed immediately to a clinical trial but we never solved the problem of how to identify the front-runners in any useful way. There are so many people trying so many things and a certain amount of variability in people's ME/CFS over time that there's such a lot of noise in the data....you might as well wait for serendipity. That has been quite useful over the years. Several drugs have com into use because they were by chance found to help. Phenylbutazone was originally used as a solvent rather than drug. Chloroquine was found useful in RA when people took antimalarials. Gold was found useful because it had been used for TB. Amantadine for Parkinson's was originally an antiviral I think. Viagra was being trialled for something else. Unless you are talking about things like aspirin reducing stroke risk over decades when most drugs work usefully it isn't difficult to notice the benefit.
This raises the question of why serendipity hasn't yet coughed up a drug for ME/CFS, given that there are presumably tens of millions of us worldwide and we've been around much longer than PwLC. Drs Fluge and Mella noticed rituximab and did a proper trial but what about all the other drugs? Are clinicians just not paying attention?How do you figure out potentially useful repurposed drugs if you have no idea what to figure? ...Across the population of people with Long Covid - say 5 million - there would be people trying almost any known prescribed drug so you might as well wait for serendipity. That has been quite useful over the years.
I wondered if we would expect serendipitous observations of IL-17 helping PwME if you're right about it but I can't find on Google that IL-17 is a drug or is used for any disease.IL-17 is a T cell derived cytokine that probably does lots of things. It seems to be involved in seronegative spondarthropathies which for me are the closest analogy I can think for what might be going on in ME/CF immunology. I don't have any more specific justification than that but at least it is about as logical as using rituximab if you think antibodies cells are involved.
I mentioned it Lipkin because he has given a presentation that mentioned IL-17 levels in ME/CFS. I seem to remember that Mady Hornig found a difference. I think the justification was moot but I would probably put it ahead of a lot of other things. IL-17 blockers have been used in other conditions and seem fairly safe.
This raises the question of why serendipity hasn't yet coughed up a drug for ME/CFS,
And screw the patients out of tens of thousands of dollars. As Eddie says bin there done that and held up research progress for decades messing about with things that do no good and may well do harm.
And talking of bin there done that ... I tried one novel drug in my career. And it worked. Because I had good reason to think it would ...
Why dismiss them out of hand? If many people report blood-letting or homeopathy improving their condition, then we should do a trial.
No, as DecodeME is only looking at people with ME/CFS. That does include a small cohort of people who report developing it following a Covid infection and who match the same selection criteria as the rest of our cohort, but that isn't the same as saying that we have a cohort of pwLC.Will DecodeME be the only GWAS to include PwLC?
There have been several GWAS on LC across the globe, some of which have been discussed on this forum. The problem, as always, has been the heterogeneity of LC.Have they still not done a GWAS on Long Covid?
There have been several GWAS on LC across the globe, some of which have been discussed on this forum. The problem, as always, has been the heterogeneity of LC.